Citius Pharmaceuticals, Inc.
NASDAQ: CTXR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Leonard L. Mazur
- Employees
- 23
- Headquarters
- Cranford, United States
- IPO year
- 2014
- Market cap
- $6.4M
- Website
- https://www.citiuspharma.com
Loading CTXR…
Loading profile data…Frequently asked questions about CTXR
What does Citius Pharmaceuticals, Inc. (CTXR) do?
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The compan...
Where does CTXR trade?
Citius Pharmaceuticals, Inc. (CTXR) trades on the NASDAQ Capital Market.
What sector is CTXR in?
Citius Pharmaceuticals, Inc. (CTXR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Citius Pharmaceuticals, Inc.?
Leonard L. Mazur is the chief executive officer of Citius Pharmaceuticals, Inc. (CTXR).
Where is Citius Pharmaceuticals, Inc. headquartered?
Citius Pharmaceuticals, Inc. is headquartered in United States.
Does CTXR pay a dividend?
Citius Pharmaceuticals, Inc. (CTXR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CTXR go public?
Citius Pharmaceuticals, Inc. (CTXR) completed its initial public offering in 2014.